ZA811791B - Quinuclindinic esters and derivatives of phenoxycarboxylic acids,a process for the preparation thereof,and related pharmaceutical compositions - Google Patents

Quinuclindinic esters and derivatives of phenoxycarboxylic acids,a process for the preparation thereof,and related pharmaceutical compositions

Info

Publication number
ZA811791B
ZA811791B ZA00811791A ZA811791A ZA811791B ZA 811791 B ZA811791 B ZA 811791B ZA 00811791 A ZA00811791 A ZA 00811791A ZA 811791 A ZA811791 A ZA 811791A ZA 811791 B ZA811791 B ZA 811791B
Authority
ZA
South Africa
Prior art keywords
sub
esters
pharmaceutical compositions
quinuclindinic
derivatives
Prior art date
Application number
ZA00811791A
Other languages
English (en)
Inventor
Reiner Alberto
Alberto Reiner
Original Assignee
D & D Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D & D Srl filed Critical D & D Srl
Publication of ZA811791B publication Critical patent/ZA811791B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/124—Acids containing four carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
ZA00811791A 1980-03-19 1981-03-18 Quinuclindinic esters and derivatives of phenoxycarboxylic acids,a process for the preparation thereof,and related pharmaceutical compositions ZA811791B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20764/80A IT1130997B (it) 1980-03-19 1980-03-19 Esteri e derivati chinucleidinici di acidi fenossicarbossilici,procedimento per la loro preparazione e relative composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
ZA811791B true ZA811791B (en) 1982-06-30

Family

ID=11171711

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00811791A ZA811791B (en) 1980-03-19 1981-03-18 Quinuclindinic esters and derivatives of phenoxycarboxylic acids,a process for the preparation thereof,and related pharmaceutical compositions

Country Status (12)

Country Link
US (1) US4355166A (xx)
EP (1) EP0036218B1 (xx)
JP (1) JPS56140991A (xx)
AT (1) ATE14583T1 (xx)
BE (1) BE887965A (xx)
CA (1) CA1160633A (xx)
DE (1) DE3171537D1 (xx)
ES (1) ES500450A0 (xx)
FR (1) FR2478638A1 (xx)
IL (1) IL62386A0 (xx)
IT (1) IT1130997B (xx)
ZA (1) ZA811791B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385912A (en) * 1991-03-08 1995-01-31 Rhone-Poulenc Rorer Pharmaceuticals Inc. Multicyclic tertiary amine polyaromatic squalene synthase inhibitors
WO1995031458A1 (en) * 1992-10-13 1995-11-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. 3-hydroxyquinuclidin-3-ylphenylquinolines as squalene synthase inhibitors
US20090054450A1 (en) * 2007-06-19 2009-02-26 Ironwood Pharmaceuticals, Inc. Compositions and methods of use for treating or preventing lipid related disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
GB1539897A (en) * 1975-02-12 1979-02-07 Orchimed Sa Phenoxypropionic acid derivatives
FR2322867A1 (fr) * 1975-09-08 1977-04-01 Merck Sharp Dohme Cie Chimique Procede de preparation d'esters de 3-quinuclidinol et d'halogenohydrates de ces esters
NL7903434A (nl) * 1978-05-09 1979-11-13 Alfa Farmaceutici Spa Derivaten van benzoylfenoxyalkaancarbonzuren met anti- lipemische en anticholesterolemische werking, alsmede farmaceutische preparaten die zo'n verbinding bevatten.

Also Published As

Publication number Publication date
FR2478638B1 (xx) 1984-01-06
US4355166A (en) 1982-10-19
IL62386A0 (en) 1981-05-20
ES8202002A1 (es) 1982-02-01
ES500450A0 (es) 1982-02-01
JPS56140991A (en) 1981-11-04
DE3171537D1 (en) 1985-09-05
EP0036218B1 (en) 1985-07-31
BE887965A (fr) 1981-07-16
EP0036218A3 (en) 1981-12-30
FR2478638A1 (fr) 1981-09-25
CA1160633A (en) 1984-01-17
IT1130997B (it) 1986-06-18
IT8020764A0 (it) 1980-03-19
EP0036218A2 (en) 1981-09-23
ATE14583T1 (de) 1985-08-15

Similar Documents

Publication Publication Date Title
ES8401089A1 (es) Metodo para la preparacion de sales monoester de acido fosfonico utilizables como compuestos fungicidas.
IE45439L (en) Penicillanic acid derivatives
ES8504682A1 (es) Un procedimiento para la preparacion de compuestos nitro alifaticos
EP0036218A3 (en) Quinuclidinic esters and derivatives of phenoxycarboxylic acids, a process for the preparation thereof, and related pharmaceutical compositions
IL74800A (en) Esters of 4-aryl-1,4,5,7-tetrahydro-5-oxothieno(3,4-b)-pyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
ES8106516A1 (es) Procedimiento de preparacion de nuevos derivados halovinca- monas y de sus sales de adicion acidas farmaceuticamente aceptables e isomeros opticamente activos de los mismos
ES8104222A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo (3,2,0) hept-2-en-2-carboxilico
ES8800217A1 (es) Procedimiento para la preparacion de acidos 4-(isoxazolil)-tiazol-2-oxamicos y sus derivados
IE45178L (en) Phenothiazine derivatives
GB1514389A (en) Glycerides with antibacterial properties
ES8706152A1 (es) Procedimiento para preparar un nuevo derivado de octahidroindol (2,3-a) quinolizina
ES8106517A1 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.
GB1500666A (en) Substituted pyrimido-quinoline derivatives and pharmaceutical compositions containing them
IE790754L (en) Substituted ethanolamines
GB2001974A (en) Vincinic acid derivatives and process for the preparation thereof
JPS55145669A (en) 8,10-diazaprostanoic acid derivative and its preparation
JPS5772981A (en) 1,8-naphthyridine derivative and its salt
ES8506015A1 (es) Procedimiento para la preparacion de esteres del acido alcoxivincaminico
JPS55151555A (en) Proline derivatives and their production
JPS5246067A (en) Reduction of optically active 5-oxo-2-pyrrolidinacetic acid esters
GB1378076A (en) N-disubstituted aminoethyl esters of 11-methoxy-raubasinic acid and preparation thereof
IE790558L (en) Pyrrolidinyl benzamides.
JPS5248666A (en) Preparation of mercaptothiazole-carboxylic acids and their esters
JPS57109742A (en) Butanediol derivative and its preparation